Quick Answer
DiaMedica Therapeutics Inc. reported Total Assets of $61.37 million for fiscal year 2025.
DiaMedica Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $61.37M | +32.4% |
| 2024 | $46.34M | -14.4% |
| 2023 | $54.16M | +57.5% |
| 2022 | $34.40M | -24.5% |
| 2021 | $45.55M | +62.1% |
| 2020 | $28.09M | +210.3% |
| 2019 | $9.05M | -50.6% |
| 2018 | $18.34M | +917.7% |
| 2017 | $1.80M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $57.05M | +8.6% | +81.3% |
| June 30, 2025 | $31.47M | -44.6% | -19.0% |
| March 31, 2025 | $38.83M | -21.2% | -16.2% |
| December 31, 2024 | $46.34M | -14.4% | -11.8% |
| September 30, 2024 | $52.52M | -9.7% | -7.5% |
| June 30, 2024 | $56.79M | -8.5% | +15.3% |
| March 31, 2024 | $49.26M | +63.0% | -9.0% |
| December 31, 2023 | $54.16M | +57.5% | -6.8% |
- DiaMedica Therapeutics Inc. showed an increase of +32.4% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, DiaMedica Therapeutics Inc.’s total assets has grown by 3305.7% (from $1.80 million to $61.37 million).
- The most recent figure is from DiaMedica Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: